Healthcare -
Biotechnology - NASDAQ - AU
$ 1.93
-0.515 %
$ 281 M
Market Cap
-8.39
P/E
IMMP - COST OF REVENUE
Cost of Revenue IMMP - Immutep Limited
41.5 M
LAST VALUE
348.71%
2 YEAR CAGR
20.15%
5 YEAR CAGR
50.15%
10 YEAR CAGR